Journals / Turkish Journal of Medical Sciences / 1998 / Cilt: 28 - Sayı: 3

Pulmonary Effects of Dexfenfluramine

Pages
239–246
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Weight reduction was obvious (f= 8.522, p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Dexfenfluramine is a variation of fenfluramine which is used for weight reduction.
📊
Key Findings & Data:A control group (n=30) and an experimintal group (n=20) was constituted.
💡
Conclusion & Impact:Weight reduction was obvious (f= 8.522, p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Dexfenfluramine · fenfluramine · obesity

Abstract

Dexfenfluramine is a variation of fenfluramine which is used for weight reduction. The aim of the study is to determine the hemodynamic and structural effects of this drug on pulmonary circulation. An experimintal study was carried out with New Zealand Rabbits. A control group (n=30) and an experimintal group (n=20) was constituted. A four-week normal diet for control group and dexfenfluramine plus normala diet for experimental group were applied. Body weights and pulmonary artery pressures of groups were recorded and lungs were collected for pathologic examination. In experimintal group; Dexfenfluramine raised systolic pulmonary artery pressures significantly (p0.05). Weight reduction was obvious (f= 8.522, p

Özet

Dexfenfluramine is a variation of fenfluramine which is used for weight reduction. The aim of the study is to determine the hemodynamic and structural effects of this drug on pulmonary circulation. An experimintal study was carried out with New Zealand Rabbits. A control group (n=30) and an experimintal group (n=20) was constituted. A four-week normal diet for control group and dexfenfluramine plus normala diet for experimental group were applied. Body weights and pulmonary artery pressures of groups were recorded and lungs were collected for pathologic examination. In experimintal group; Dexfenfluramine raised systolic pulmonary artery pressures significantly (p0.05). Weight reduction was obvious (f= 8.522, p

🔖

Cite This Article

CANDAN, F., AKSOY, M., DOĞAN, K., EĞİLMEZ, R., YALMAN, Y., BEKAR, E., GÜLTEKİN, F., KAPTANOĞLU, M. (2022). Pulmonary Effects of Dexfenfluramine. Turkish Journal of Medical Sciences, Cilt: 28 - Sayı: 3, 239–246. https://ajindex.com/articles/612657

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...